Acorah Software Products - Accounts Production 16.8.310 false true 30 September 2024 1 October 2023 false 1 October 2024 30 September 2025 30 September 2025 09798386 Dr Baljit Johal Mr Anureet Singh Johal iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09798386 2024-09-30 09798386 2025-09-30 09798386 2024-10-01 2025-09-30 09798386 frs-core:CurrentFinancialInstruments 2025-09-30 09798386 frs-core:FurnitureFittings 2025-09-30 09798386 frs-core:FurnitureFittings 2024-10-01 2025-09-30 09798386 frs-core:FurnitureFittings 2024-09-30 09798386 frs-core:PlantMachinery 2025-09-30 09798386 frs-core:PlantMachinery 2024-10-01 2025-09-30 09798386 frs-core:PlantMachinery 2024-09-30 09798386 frs-core:ShareCapital 2025-09-30 09798386 frs-core:RetainedEarningsAccumulatedLosses 2025-09-30 09798386 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 09798386 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 09798386 frs-bus:SmallEntities 2024-10-01 2025-09-30 09798386 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 09798386 frs-bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 09798386 frs-bus:Director1 2024-10-01 2025-09-30 09798386 frs-bus:Director2 2024-10-01 2025-09-30 09798386 frs-countries:EnglandWales 2024-10-01 2025-09-30 09798386 2023-09-30 09798386 2024-09-30 09798386 2023-10-01 2024-09-30 09798386 frs-core:CurrentFinancialInstruments 2024-09-30 09798386 frs-core:ShareCapital 2024-09-30 09798386 frs-core:RetainedEarningsAccumulatedLosses 2024-09-30
Registered number: 09798386
Richmond Dermatology Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2025
Richmond Dermatology Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—5

Page 1
Richmond Dermatology Ltd
Balance Sheet
As At 30 September 2025
Balance Sheet
Registered number: 09798386

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 2 |  | 2
|  |  | 2 |  | 2
CURRENT ASSETS
Stocks | 5 | - |  | 500 |
Debtors | 6 | 120 |  | 1,450 |
Cash at bank and in hand |  | 153,929 |  | 141,524 |
|  | 154,049 |  | 143,474 |
Creditors: Amounts Falling Due Within One Year | 7 | (6,875 ) |  | (5,665 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 147,174 |  | 137,809
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 147,176 |  | 137,811
NET ASSETS |  |  | 147,176 |  | 137,811
CAPITAL AND RESERVES
Called up share capital | 8 |  | 10,000 |  | 10,000
Profit and Loss Account |  |  | 137,176 |  | 127,811
SHAREHOLDERS' FUNDS |  |  | 147,176 |  | 137,811

Page 1
Page 2
Richmond Dermatology Ltd
Balance Sheet (continued)
As At 30 September 2025
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr Baljit Johal Director
06/03/2026

The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Richmond Dermatology Ltd
Notes to the Financial Statements
For The Year Ended 30 September 2025
Notes to the Financial Statements
1. General Information
Richmond Dermatology Ltd is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery | 20% on Cost
Fixtures & Fittings | 20% on Cost

2.4. Stocks and Work in Progress
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
...CONTINUED
Page 3
Page 4
Richmond Dermatology Ltd
Notes to the Financial Statements (continued)
For The Year Ended 30 September 2025
2.5. Taxation - continued
Current or deferred tax for the year is recognised in profit or loss, except when they related
to items that are recognised in other comprehensive income or directly in equity, in which
case, the current and deferred tax is also recognised in other comprehensive income or
directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
4. Tangible Assets

| Plant & Machinery | Fixtures & Fittings | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 October 2024 | 1,595 | 2,307 | 3,902
As at 30 September 2025 | 1,595 | 2,307 | 3,902
Depreciation
As at 1 October 2024 | 1,594 | 2,306 | 3,900
As at 30 September 2025 | 1,594 | 2,306 | 3,900
Net Book Value
As at 30 September 2025 | 1 | 1 | 2
As at 1 October 2024 | 1 | 1 | 2

5. Stocks

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Stock | - |  | 500

6. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 120 |  | -
Other debtors | - |  | 1,450
| 120 |  | 1,450

Page 4
Page 5
Richmond Dermatology Ltd
Notes to the Financial Statements (continued)
For The Year Ended 30 September 2025
7. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | 77 |  | -
Corporation tax | 2,197 |  | 1,064
Accruals and deferred income | 1,260 |  | 1,260
Directors' loan accounts | 3,341 |  | 3,341
| 6,875 |  | 5,665

8. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 10,000 |  | 10,000

Page 5